<DOC>
	<DOCNO>NCT02647853</DOCNO>
	<brief_summary>This Phase 1 , randomize , placebo-controlled , double-blind , healthy volunteer study test safety , tolerability , plasma pharmacokinetics two different concentration TAT4 Gel administer daily 50 cm2 skin 14 day .</brief_summary>
	<brief_title>Phase 1 Study Assess Safety Tolerability TAT4 Gel Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Men woman 4070 year old Healthy volunteer Provision inform consent History skin hypersensitivity Abnormality screening assessment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>